secwatch / observer
8-K filed November 16, 2023, 6:59 PM ET ticker ALZN CIK 0001677077
other material confidence high sentiment positive materiality 0.70

Alzamend Neuro, Inc. (ALZN): Nasdaq/NYSE listing notice — Alzamend Neuro regains Nasdaq minimum bid price compliance

Alzamend Neuro, Inc.

Key facts

Extracted from this filing and checked against the source text.

Listing & Compliance Notices SEC 8-K Item 3.01 confidence 0.9

Alzamend Neuro, Inc. received a nasdaq deficiency notice notice regarding minimum bid price.

Exchange
nasdaq
Notice
deficiency notice
Deficiency
minimum bid price
Exact text from the filing
November 15, 2023. On November 15, 2023, the Company received notice from Nasdaq that the Company has regained compliance with the Minimum Bid Price Requirement and stated that the matter is now closed. On November 16, 2023, the Company issued a press release to announce that the Company has regained compliance with the Minimum Bid Price Requirement. A copy of the press release is furnished herewith as Exhibit 99.1 and is incorporated by reference herein. In accordance with General Instruction B.2 of Form 8-K, the information under this item shall not be deemed filed for purposes of Section 18
View on SEC.gov

Browse all listing & compliance notices →

Alzamend Neuro, Inc. filing history →

Source: SEC EDGAR
accession 0001214659-23-015278
Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.